1.Effect of Dingguier umbilical paste on rats with functional dyspepsia and mice with splenic asthenia.
Jian-Li MA ; Si-Jun ZHAO ; Ting-Ting WANG ; Jin-Hua PIAO ; Xiang LI ; Lei GAO ; Xiao-Qing WANG
China Journal of Chinese Materia Medica 2013;38(7):1067-1070
OBJECTIVETo observe the effect of Dingguier umbilical paste on rats with functional dyspepsia and mice with splenic asthenia, and investigate the related mechanism.
METHODFunctional dyspepsia models of rats were made by irregular food intake plus diluted hydrochloric acid. Successional treatments were offered for 14 days. The rats weights, contents of serum NO, AChE and MC were measured. The rats with splenic asthenia were made by rhubarb feed, and observed the affection of gastric emptying.
RESULTCompared with those in the model control group, the weight of rats in all dosages Dingguier umbilical paste groups increased obviously (P < 0.05), pepsin activity of rats in the dosage (1.34 g x kg(-1)) Dingguier umbilical paste groups was significantly higher and the contents of NO and quantities of MC in the dosage (2.67 g x kg(-1)) Dingguier umbilical paste groups decreased clearly (P < 0.05), and the contents of serum AChE in all dosages Dingguier umbilical paste groups rose apparently. The weight of mice with splenic asthenia increased obviously, accelerated gastric emptying, and improved the symptom.
CONCLUSIONDingguier umbilical paste has significant improvement of indigestion. The related mechanism may be to reduce the content of serum NO and the quantity of MC and enhance the content of serum AChE.
Animals ; Asthenia ; drug therapy ; pathology ; physiopathology ; Body Weight ; drug effects ; Drugs, Chinese Herbal ; administration & dosage ; Dyspepsia ; drug therapy ; physiopathology ; Eating ; drug effects ; Female ; Gastric Emptying ; drug effects ; Humans ; Male ; Mice ; Rats ; Rats, Wistar ; Spleen ; drug effects ; pathology ; Umbilicus
2.Pathologic Complete Remission in a Patient with Locally Advanced Unresectable Intrahepatic Cholangiocarcinoma Treated with Chemotherapy.
Hyo Jun YANG ; Ji Kon RYU ; Woo Hyun PAIK ; Sang Hyub LEE ; Yong Tae KIM ; Kyoungbun LEE
Korean Journal of Pancreas and Biliary Tract 2017;22(4):188-192
A 54-year-old female with postprandial dyspepsia and abdominal pain was diagnosed as locally advanced unresectable intrahepatic cholangiocarcinoma by radiologic imaging studies resulting in invasion to bilateral main bile duct and right portal vein. The patient underwent extended right hepatectomy and portal vein resection after gemcitabine and cisplatin combined chemotherapy for a total of 40 cycles after the diagnosis. Final pathology showed, followed by pathological complete remission, without any residual cancer cell. The patient has survived for over 6 years without any evidence of recurrence. This case suggests that locally advanced intrahepatic cholangiocarcinoma, which can't be resected, was also proved to be capable of pathological complete remission with active chemotherapy, and long-term survival could be achieved. Therefore, active multidisciplinary approach and patient-oriented treatments using various methods should be considered for locally advanced unresectable intrahepatic cholangiocarcinoma.
Abdominal Pain
;
Bile Duct Neoplasms
;
Bile Ducts
;
Cholangiocarcinoma*
;
Cisplatin
;
Diagnosis
;
Drug Therapy*
;
Dyspepsia
;
Female
;
Hepatectomy
;
Humans
;
Middle Aged
;
Neoplasm, Residual
;
Pathology
;
Portal Vein
;
Recurrence
3.Factors Associated with Fatigue in Korean Gastric Cancer Survivors.
Wan PARK ; Jung Kwon LEE ; Cho Rong KIM ; Jin Young SHIN
Korean Journal of Family Medicine 2015;36(6):328-334
BACKGROUND: Gastric cancer is the second most common cancer in Korea. Fatigue is a common symptom among cancer survivors. The aim of this study was to identify factors associated with fatigue in gastric cancer survivors. METHODS: Data were analyzed from 199 gastric cancer survivors who visited a cancer survivor outpatient clinic from July 2013 to June 2014. Patients were surveyed using a questionnaire containing a fatigue severity scale (FSS) and questions regarding associated symptoms. Participants were divided into fatigue (FSS) and non-fatigue groups based on FSS scores (> or =4 and <4, respectively). Age, sex, weight, body mass index, cancer stage, pathology, surgery type, chemotherapy, radiotherapy, comorbid disease, family history of cancer, smoking, alcohol consumption, exercise, and laboratory results were investigated. RESULTS: The fatigue and non-fatigue groups contained 42 and 157 survivors, respectively. Their mean age was 58 years, and the mean post-operative period was 6.58 years. Arthralgia (odds ratio [OR], 12.95; 95% confidence interval [CI], 3.21-52.34), dyspnea (OR, 10.54; 95% CI, 2.94-37.80), dyspepsia (OR, 8.26; 95% CI, 2.63-25.96), changed bowel habits (OR, 4.56; 95% CI, 1.09-19.11), anemia (OR, 3.18; 95% CI, 1.26-8.05), and regular exercise (OR, 0.31; 95% CI, 0.12-0.77) were significantly associated with fatigue in gastric cancer survivors, while weight, treatment, and depressive mood were not. CONCLUSION: Arthralgia, dyspnea, dyspepsia, bowel habit change, anemia, and regular exercise are associated with fatigue in gastric cancer survivors.
Alcohol Drinking
;
Ambulatory Care Facilities
;
Anemia
;
Arthralgia
;
Body Weight
;
Drug Therapy
;
Dyspepsia
;
Dyspnea
;
Fatigue*
;
Humans
;
Korea
;
Pathology
;
Radiotherapy
;
Smoke
;
Smoking
;
Stomach Neoplasms*
;
Survivors*
4.Efficacy and Safety of New Prokinetic Agent Benachio Q Solution(R) in Patients with Postprandial Distress Syndrome Subtype in Functional Dyspepsia: A Single-center, Randomized, Double-blind, Placebo-controlled Pilot Study.
Young Kwang SHIM ; Ju Yup LEE ; Nayoung KIM ; Yo Han PARK ; Hyuk YOON ; Cheol Min SHIN ; Young Soo PARK ; Dong Ho LEE
The Korean Journal of Gastroenterology 2015;66(1):17-26
BACKGROUND/AIMS: Functional dyspepsia (FD) is a gastrointestinal disorder in which the patient suffers from chronic abdominal symptoms despite the absence of organic disease. Benachio Q solution (soln.)(R) is a new prokinetic herbal medicine. The aim of the present study is to determine the efficacy and safety of Benachio Q soln.(R) in patients with postprandial distress syndrome (PDS) subtype in FD. METHODS: A single-center, randomized, double-blind, placebo-controlled pilot study was performed in 20 patients with PDS. Patients were assigned to receive either Benachio Q soln.(R) or placebo three times a day. After 4 weeks of treatment, the data on response rates, symptoms severity of PDS and gastric emptying time were analyzed to evaluate its efficacy. Adverse events, laboratory tests and vital sign were analyzed to assess its safety. RESULTS: Nine patients were assigned to Benachio group and 10 patients to placebo group. The response rate after 4 weeks was 44.4% and 20.0% in Benachio and placebo group, respectively (p=0.350). The response rate during the first week in Benachio group was better compared to that of placebo group with marginal difference (33.3% vs. 0.0%, p=0.087). Changes of severity score in early satiety on second and third week were -1.8+/-0.6, -1.9+/-0.4 and -1.3+/-0.5, -1.4+/-0.6 in Benachio and placebo group, respectively (p=0.059 vs. p=0.033). No adverse event was observed. CONCLUSIONS: The new herbal drug, Benachio Q soln.(R) seems to improve the symptoms of PDS subtype in FD and could be used safely. Further larger trial is needed in the future.
Adult
;
Double-Blind Method
;
Drug Administration Schedule
;
Dyspepsia/*drug therapy/pathology
;
Female
;
Gastrointestinal Agents/*therapeutic use
;
*Herbal Medicine
;
Humans
;
Male
;
Middle Aged
;
Pilot Projects
;
Placebo Effect
;
Postprandial Period
;
Severity of Illness Index
;
Treatment Outcome
5.Improved Survival of a Patient with Gastric and Other Multiple Metastases from Ovarian Cancer by Multimodal Treatment: A Case Report.
Seonmi HWANGBO ; Oh Kyoung KWON ; Ho Young CHUNG ; Wansik YU
Journal of Gastric Cancer 2015;15(3):218-221
Gastric metastasis from ovarian carcinoma is extremely rare and the prognosis for patients is poor. We report a case of multimodal treatment improving the survival time of a patient with gastric metastasis from ovarian cancer. A 73-year-old woman with known serous ovarian cancer was admitted to the hospital due to epigastric pain and dyspepsia. On esophagogastroduodenoscopy, a protruding mass was noted at the gastric antrum. She underwent distal gastrectomy with Billroth I anastomosis and lymph node dissection, including the para-aortic lymph nodes. The final pathology revealed gastric metastasis from ovarian serous adenocarcinoma. In this case, after cytoreductive surgery, chemotherapy was performed each time a recurrence was diagnosed, and remission was accomplished. She survived for 108 months after the first diagnosis of the metastatic tumor in the stomach. Multimodal treatment of metastatic lesions since the first diagnosis allowed the patient to survive longer than those in previous reports.
Adenocarcinoma
;
Aged
;
Combined Modality Therapy*
;
Diagnosis
;
Drug Therapy
;
Dyspepsia
;
Endoscopy, Digestive System
;
Female
;
Gastrectomy
;
Gastroenterostomy
;
Humans
;
Lymph Node Excision
;
Lymph Nodes
;
Neoplasm Metastasis*
;
Ovarian Neoplasms*
;
Pathology
;
Prognosis
;
Pyloric Antrum
;
Recurrence
;
Stomach